• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Nurix Therapeutics, Inc. - Common stock (NQ:NRIX)

18.49 +1.06 (+6.08%)
Streaming Delayed Price Updated: 4:00 PM EST, Jan 7, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,734,473
Open 17.56
Bid (Size) 16.50 (100)
Ask (Size) 18.43 (300)
Prev. Close 17.43
Today's Range 17.45 - 19.06
52wk Range 8.180 - 22.50
Shares Outstanding 47,147,781
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Precision's Payoff: Targeted Therapies Drive $131B Solid Tumor Market Surge
December 24, 2025
Issued on behalf of GT Biopharma, Inc. 
From Equity Insider
Via GlobeNewswire
News headline image
13 Analysts Have This To Say About Nurix Therapeutics ↗
November 04, 2025
 
Via Benzinga

Performance

YTD
+2.4%
+2.4%
1 Month
-13.9%
-13.9%
3 Month
+85.3%
+85.3%
6 Month
+40.3%
+40.3%
1 Year
-2.2%
-2.2%

More News

Read More
News headline image
Nurix Therapeutics (NASDAQ: NRIX) Stock Soars as Pivotal Phase 2 Study for Bexobrutideg Ignites Investor Confidence
October 22, 2025
Via MarketMinute
Nurix Stock Falls After-Hours After Wider Q3 Loss; Oppenheimer Sees FDA Support For Bexo, Retail Buys The Dip ↗
October 09, 2025
Via Stocktwits
News headline image
Breaking Down Nurix Therapeutics: 5 Analysts Share Their Views ↗
October 10, 2025
Via Benzinga
News headline image
Nurix Therapeutics Posts Downbeat Q3 Results, Joins Orthopediatrics, Levi Strauss And Other Big Stocks Moving Lower In Friday's Pre-Market Session ↗
October 10, 2025
Via Benzinga
News headline image
Why Applied Digital Shares Are Trading Higher By Around 25%; Here Are 20 Stocks Moving Premarket ↗
October 10, 2025
Via Benzinga
News headline image
Levi Strauss, USANA Health Sciences And 3 Stocks To Watch Heading Into Friday ↗
October 10, 2025
Via Benzinga
News headline image
8 Analysts Have This To Say About Nurix Therapeutics ↗
January 29, 2025
Via Benzinga
News headline image
NURIX THERAPEUTICS INC (NASDAQ:NRIX) Misses Q3 2025 Estimates, Shares Drop ↗
October 09, 2025
Via Chartmill
News headline image
6 Analysts Assess Nurix Therapeutics: What You Need To Know ↗
July 31, 2025
Via Benzinga
News headline image
12 Health Care Stocks Moving In Thursday's After-Market Session ↗
July 17, 2025
Via Benzinga
News headline image
Which stocks are moving after the closing bell on Thursday? ↗
July 17, 2025
Via Chartmill
News headline image
A Glimpse Into The Expert Outlook On Nurix Therapeutics Through 5 Analysts ↗
July 14, 2025
Via Benzinga
News headline image
Amazon To Rally Around 28%? Here Are 10 Top Analyst Forecasts For Thursday ↗
July 10, 2025
Via Benzinga
News headline image
12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗
July 10, 2025
Via Benzinga
News headline image
Why WK Kellogg Shares Are Trading Higher By Over 50%; Here Are 20 Stocks Moving Premarket ↗
July 10, 2025
Via Benzinga
News headline image
Nurix Therapeutics Posts Better-Than-Expected Q2 Results; Revenue Soars on Sanofi and Gilead Payments ↗
July 09, 2025
Via Stocktwits
News headline image
12 Health Care Stocks Moving In Wednesday's After-Market Session ↗
July 09, 2025
Via Benzinga
News headline image
What's going on in today's after hours session ↗
July 09, 2025
Via Chartmill
News headline image
Sanofi Expands Rare Immunology Portfolio With Blueprint Buyout ↗
June 02, 2025
Via Benzinga
News headline image
Breaking Down Nurix Therapeutics: 7 Analysts Share Their Views ↗
April 29, 2025
Via Benzinga
News headline image
Cathie Wood Buys More NVIDIA And AMD Stock As Chinese Tech Giants Stockpile Chips Amid Looming US Export Curbs ↗
April 23, 2025
Via Benzinga
News headline image
Expert Outlook: Nurix Therapeutics Through The Eyes Of 9 Analysts ↗
April 02, 2025
Via Benzinga
News headline image
Beyond The Numbers: 8 Analysts Discuss Nurix Therapeutics Stock ↗
March 17, 2025
Via Benzinga

Frequently Asked Questions

Is Nurix Therapeutics, Inc. - Common stock publicly traded?
Yes, Nurix Therapeutics, Inc. - Common stock is publicly traded.
What exchange does Nurix Therapeutics, Inc. - Common stock trade on?
Nurix Therapeutics, Inc. - Common stock trades on the Nasdaq Stock Market
What is the ticker symbol for Nurix Therapeutics, Inc. - Common stock?
The ticker symbol for Nurix Therapeutics, Inc. - Common stock is NRIX on the Nasdaq Stock Market
What is the current price of Nurix Therapeutics, Inc. - Common stock?
The current price of Nurix Therapeutics, Inc. - Common stock is 18.49
When was Nurix Therapeutics, Inc. - Common stock last traded?
The last trade of Nurix Therapeutics, Inc. - Common stock was at 01/07/26 04:00 PM ET
What is the market capitalization of Nurix Therapeutics, Inc. - Common stock?
The market capitalization of Nurix Therapeutics, Inc. - Common stock is 871.76M
How many shares of Nurix Therapeutics, Inc. - Common stock are outstanding?
Nurix Therapeutics, Inc. - Common stock has 872M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap